Ascendis Pharma A/S NASDAQ NMS - GLOBAL MARKET:ASND
The leadership team, board of directors, and 10% beneficial owners of Ascendis Pharma A/S, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Cha Albert
—3,730 sharesFairey William
—2,117 sharesHOLTUG LARS
—4,236 sharesIMANI SIHAM
—2,317 sharesJENSEN FLEMMING STEEN
—19,460 sharesMIKKELSEN JAN MOLLER
—68,470 sharesMorrison Lisa
—1,572 sharesPEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG
—19,460 sharesSMITH SCOTT THOMAS
—2,517 sharesSPROGOE KENNETT
—19,460 sharesWu Jay Donovan
—1,068 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.